Frequently Asked Questions
The market is segmented based on Global Dementia - Alzheimer Disease Market, By Drug Class (Cholinergic/Cholinesterase (ChE) Inhibitors, Memantine, and Combined Drug), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Sales) - Industry Trends and Forecast to 2030.
.
The Global Dementia Alzheimer Disease Market size was valued at USD 13000.00 USD Million in 2022.
The Global Dementia Alzheimer Disease Market is projected to grow at a CAGR of 8.5% during the forecast period of 2023 to 2030.
The major players operating in the market include Merz Pharma GmbH & Co. KGaA, Novartis AG, Pfizer , Ono Pharmaceutical Co. , Johnson & Johnson Services , H. Lundbeck A/S, F. Hoffmann-La Roche , AbbVie , Eli Lilly and Company, Corium ,
-.
The market report covers data from the U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E, South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina and rest of South America.
